Liquidia Corporation (LQDA)
NASDAQ: LQDA · Real-Time Price · USD
21.80
-0.65 (-2.90%)
At close: Sep 26, 2025, 4:00 PM EDT
21.95
+0.15 (0.69%)
After-hours: Sep 26, 2025, 5:56 PM EDT
Liquidia Market Cap
Liquidia has a market cap or net worth of $1.88 billion as of September 26, 2025. Its market cap has increased by 121.99% in one year.
Market Cap
1.88B
Enterprise Value
1.90B
1-Year Change
121.99%
Ranking
Category
Stock Price
$21.80
Market Cap Chart
Since July 26, 2018, Liquidia's market cap has increased from $167.77M to $1.88B, an increase of 1,018.64%. That is a compound annual growth rate of 40.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 1.88B | 88.56% |
| Dec 31, 2024 | 995.33M | 20.97% |
| Dec 29, 2023 | 822.82M | 100.28% |
| Dec 30, 2022 | 410.83M | 62.30% |
| Dec 31, 2021 | 253.13M | 98.01% |
| Dec 31, 2020 | 127.84M | 60.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.45B |
| Johnson & Johnson | 432.80B |
| AbbVie | 389.72B |
| UnitedHealth Group | 311.62B |
| Novo Nordisk | 242.68B |
| Novartis AG | 238.65B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 228.75B |